University of Minnesota. Driven to Discover.
The Obama administration unveils a plan for addressing the threat in the next 5 years.
Steps include added lab capacity, a sequencing database, and boosts for drug development.
The test checks patient specimens for the presence of 5 different genetic markers.
Two studies show the potential of genetics to quickly tell bacterial from viral infections in feverish infants.
The test could reduce the likelihood of antibiotic-pathogen mismatch by almost 67%.
Meta-analysis shows a 21% higher antibiotic prescribing rate in patients who tested negative for malaria.
Though results are mixed, point-of-care testing could reduce antibiotic use.
A national lab network can identify emerging threats and track resistance trends.
The alliance aims to aid collaboration between the public and private sectors.
"If we can eradicate the empirical use of antibiotics . . . we can achieve a lot," Zowawi says.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.